The ColumbianBiotech firms tests cell therapy for cancerThe ColumbianCAR-T cell therapy for aggressive B cell Non-Hodgkin lymphoma, the form of cancer Symes had, is the most promising product in the pipeline of Seattle-based biotech company Juno Therap… Continue reading
Cancer Immunotherapy Market Research Report: Building on Initial Successes to Improve Clinical OutcomesGlobeNewswire (press release)Moreover, treatment of advanced melanoma (the cancer for which the largest amount of data on immunotherapy has been amas… Continue reading
Cancer Immunotherapy Market Research Report: Building on Initial Successes to Improve Clinical OutcomesGlobeNewswire (press release)Moreover, treatment of advanced melanoma (the cancer for which the largest amount of data on immunotherapy has been amas… Continue reading
Multiple Sclerosis News Today |
MS Gene Therapy Shows Good Results in Mice, but Human Trials Remain Distant
Multiple Sclerosis News Today Researchers have taken the first steps towards the development of a gene therapy for multiple sclerosis — a treatment that boosted anti-inflammatory immune processes and reversed severe paralysis in mouse models of the disease. The University of … New gene therapy prevents MS and reverses paralysis in miceNew Atlas |
|
Chemistry Nobel predictions range from perovskites to Crispr
Chemistry World (subscription) As excitement builds once more, analysts and online commentators are making their predictions on who they think has a chance of securing science’s top gong, with suggestions ranging from Crispr to heterogeneous catalysis and perennial also-ran the … |